These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. You're the flight surgeon: bladder cancer. Egerstrom K Aviat Space Environ Med; 2010 Feb; 81(2):154-5. PubMed ID: 20131661 [No Abstract] [Full Text] [Related]
45. Active Surveillance or Office Fulguration for Low Grade Ta Bladder Tumors: A Win-Win for Patients and Urologists. Soloway MS J Urol; 2018 May; 199(5):1120-1122. PubMed ID: 28987859 [No Abstract] [Full Text] [Related]
47. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up. Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058 [TBL] [Abstract][Full Text] [Related]
48. Is it time to re-design the haematuria clinic? Mostafid H; Persad R; Kockelbergh R; Fawcett D BJU Int; 2010 Mar; 105(5):585-8. PubMed ID: 20002672 [No Abstract] [Full Text] [Related]
49. [Can MRI be used to distinguish between superficial and invasive transitional cell bladder cancer?]. Tillou X; Grardel E; Fourmarier M; Bernasconi T; Demailly M; Hakami F; Saint F; Petit J Prog Urol; 2008 Jul; 18(7):440-4. PubMed ID: 18602604 [TBL] [Abstract][Full Text] [Related]
50. Recent advances in diagnosis and treatment of transitional cell carcinoma of the bladder. Martyn-Hemphill C; Mak D; Khan MS; Challacombe BJ; Bishop CV Int J Surg; 2013; 11(9):749-52. PubMed ID: 24013072 [TBL] [Abstract][Full Text] [Related]
51. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510 [TBL] [Abstract][Full Text] [Related]
52. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer. Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912 [TBL] [Abstract][Full Text] [Related]
56. The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy. Cho KS; Seo JW; Park SY; Cho NH; Choi YD; Yang SC; Hong SJ Urol Int; 2008; 81(4):394-8. PubMed ID: 19077398 [TBL] [Abstract][Full Text] [Related]
57. [Superficial bladder carcinoma -- trend of less aggressive therapies]. Friedrich MG Aktuelle Urol; 2006 Jul; 37(4):254-6. PubMed ID: 16955957 [No Abstract] [Full Text] [Related]
58. Micropapillary transitional cell carcinoma of the urinary bladder: report of two cases. Dhouib RS; Abbes I; Mrad K; Sassi S; Leila A; Driss M; Salah R; Romdhane KB Pathologica; 2005 Oct; 97(5):338-40. PubMed ID: 16480033 [TBL] [Abstract][Full Text] [Related]
59. Superficial bladder cancer: timing of check cystoscopies in the first year. Morris SB; Shearer RJ; Gordon EM; Woodhouse CR Br J Urol; 1993 Oct; 72(4):446-8. PubMed ID: 8261301 [TBL] [Abstract][Full Text] [Related]
60. Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. Yossepowitch O; Dalbagni G J Urol; 2002 Jul; 168(1):61-6. PubMed ID: 12050493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]